Who founded Manifold Biotechnologies?

Manifold Biotechnologies was founded by Gleb Kuznetsov, Pierce Ogden in 2019.

Who are Manifold Biotechnologies's investors?

Manifold Biotechnologies's investors include Third Rock Ventures.

How much funding has Manifold Biotechnologies raised?

Manifold Biotechnologies has disclosed $78.2M raised across 3 rounds.

Where is Manifold Biotechnologies headquartered?

Manifold Biotechnologies is headquartered in Boston, US.

Manifold Biotechnologies

Boston, US · Founded 2019 · Delaware corporation · 1 known investors

Find your way into Manifold Biotechnologies

644 people in our graph share verified history with the Manifold Biotechnologies team — schools, employers, funds. One of them is your warm intro.

Yaryna Nychunlockedknows Pierce Ogden · together at Harvard University (overlapped)

×5knows the team · via Harvard University

×4knows the team · via Harvard Medical School

×2knows the team · via University of San Francisco

Biotech

Founders & leadership

Manifold Biotechnologies was founded in 2019 by Gleb Kuznetsov and Pierce Ogden.

Gleb KuznetsovinCo-founderCo-Founder & CEO at Manifold

Pierce Ogden inCo-founderPierce Ogden is co-founder and CTO of Manifold Biotechnologies, where he developed the M-Codes technology platform for tracking protein therapeutics. Previously, he led AAV variant screening research in the Church lab using DNA synthesis and sequencing methods, contributing to the founding of Dyno Therapeutics.

Board

Jory BellBoard director

Jeff HuberBoard director

Steven J. KafkaBoard director

Steven HoltzmanBoard director

Investors · 1

Third Rock VenturesreportedBoston · $100K – $5M

Reported raises · per SEC filings

Form D private placements

$78.2M disclosed across 3 rounds · 2020–2024

▶$32.8MraisedDec 2024 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jory BellDirector
Gleb KuznetsovExecutive Officer, Director
Jeff HuberDirector
Pierce OgdenExecutive Officer, Director
Steven J. KafkaDirector
Steven HoltzmanDirector

Offering amount: $32.8M
Amount sold: $32.8M
First sale: Nov 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$40MraisedJun 2022 · 13 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jeff HuberDirector
Pierce OgdenExecutive Officer, Director, Promoter
Gleb KuznetsovExecutive Officer, Director, Promoter
Jory BellDirector

Offering amount: $40M
Amount sold: $40M
First sale: May 2022
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.4MraisedAug 2020 · 6 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Pierce OgdenExecutive Officer, Director, Promoter
Gleb KuznetsovExecutive Officer, Director, Promoter
Jory BellDirector

Offering amount: $5.4M
Amount sold: $5.4M
First sale: Jul 2020
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Manifold Biotechnologies has filed a notice of an exempt offering of securities to raise $32,784,801.00 in New Equity Investment. - intelligence360intelligence360.news · Dec 2024

Frequently asked questions

Who founded Manifold Biotechnologies?: Manifold Biotechnologies was founded by Gleb Kuznetsov, Pierce Ogden in 2019.
Who are Manifold Biotechnologies's investors?: Manifold Biotechnologies's investors include Third Rock Ventures.
How much funding has Manifold Biotechnologies raised?: Manifold Biotechnologies has disclosed $78.2M raised across 3 rounds.
Where is Manifold Biotechnologies headquartered?: Manifold Biotechnologies is headquartered in Boston, US.